This topic contains a solution. Click here to go to the answer

Author Question: The dosage of cyclosporine would need to be increased if the patient is also receiving: a. ... (Read 142 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
The dosage of cyclosporine would need to be increased if the patient is also receiving:
 
  a. phenytoin.
  b. prednisone.
  c. ketoconazole.
  d. amphotericin B.

Question 2

The physician prescribes sumatriptan for a patient's headache. Before administering this drug, the nurse should gather which assessment information?
 
  a. Does the patient have a family history of migraines?
  b. Has the patient taken ergotamine in the past 24 hours?
  c. Has the patient taken acetaminophen in the past 3 hours?
  d. Is the patient allergic to sulfa compounds?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yifu223

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

a

Answer to Question 2

b




crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


smrtceo

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library